Featured Research

from universities, journals, and other organizations

Among patients with infective endocarditis and heart failure, valvular surgery associated with reduced mortality

Date:
November 29, 2011
Source:
JAMA and Archives Journals
Summary:
Among patients with infective endocarditis and heart failure, about two-thirds undergo valvular surgery, which is associated with a significant reduction in the risk of death in the hospital and at one year, according to a new study.

Among patients with infective endocarditis (an infection of the heart lining which may involve the heart valves) and heart failure, about two-thirds undergo valvular surgery, which is associated with a significant reduction in the risk of death in the hospital and at one year, according to a study in the Nov. 23/30 issue of JAMA.

Related Articles


"Infective endocarditis is associated with substantial morbidity and mortality. Several published studies have reported in-hospital mortality of 15 percent to 20 percent and l-year mortality of 40 percent. In the United States alone, approximately 15,000 new cases of infective endocarditis are diagnosed each year. A variety of complications contribute to the high rates of morbidity and mortality in infective endocarditis, particularly heart failure (HF), which occurs in approximately 40 percent of patients," according to background information in the article. Several observational studies have shown a reduction in the risk of death for infective endocarditis complicated by HF with valvular surgery, and this indication for surgery is strongly recommended in current American College of Cardiology/American Heart Association and European Society of Cardiology guidelines.

Todd Kiefer, M.D., Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues conducted a study to examine the clinical, echocardiography, and microbiological variables associated with the development of HF in patients with infective endocarditis and examined variables associated with in-hospital and 1-year mortality, including the use and effects of surgery on outcome. The study included 4,166 patients with native- or prosthetic-valve infective endocarditis from 61 centers in 28 countries between June 2000 and December 2006.

Among 4,075 patients with infective endocarditis and known HF status, 1,359 (33.4 percent) had HF, and 906 (66.7 percent) were classified as having New York Heart Association class III or IV symptom status (greater degree of limitations/symptoms with physical activity). Within the subset with HF, 839 (61.7 percent) underwent valvular surgery during the index hospitalization. The researchers found that in-hospital mortality was 29.7 percent for the entire HF cohort, with lower mortality observed in patients undergoing valvular surgery compared with medical therapy alone (20.6 percent vs. 44.8 percent, respectively). In addition, one-year mortality was 29.1 percent in patients undergoing valvular surgery vs. 58.4 percent in those not undergoing surgery.

Factors independently associated with 1-year mortality included advanced age, diabetes mellitus, health care-associated infection, causative microorganism (Staphylococcus aureus or fungi), severe HF (New York Heart Association class III or IV), stroke, and paravalvular complications. Valvular surgery during the initial hospitalization was associated with lower mortality.

The authors note that their finding that nearly one-third of patients with HF and high surgical propensity did not have surgery emphasizes the need for multi-disciplinary, guideline-based management of infective endocarditis. "Improved recognition of HF and institutional systems to promote appropriate treatment of infective endocarditis may enhance the rate of surgery for this indication."

"Additional studies are needed to better risk-stratify patients with infective endocarditis and HF and optimize the use of surgery for this serious condition."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. T. Kiefer, L. Park, C. Tribouilloy, C. Cortes, R. Casillo, V. Chu, F. Delahaye, E. Durante-Mangoni, J. Edathodu, C. Falces, M. Logar, J. M. Miro, C. Naber, M. F. Tripodi, D. R. Murdoch, P. Moreillon, R. Utili, A. Wang. Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure. JAMA: The Journal of the American Medical Association, 2011; 306 (20): 2239 DOI: 10.1001/jama.2011.1701

Cite This Page:

JAMA and Archives Journals. "Among patients with infective endocarditis and heart failure, valvular surgery associated with reduced mortality." ScienceDaily. ScienceDaily, 29 November 2011. <www.sciencedaily.com/releases/2011/11/111122162822.htm>.
JAMA and Archives Journals. (2011, November 29). Among patients with infective endocarditis and heart failure, valvular surgery associated with reduced mortality. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2011/11/111122162822.htm
JAMA and Archives Journals. "Among patients with infective endocarditis and heart failure, valvular surgery associated with reduced mortality." ScienceDaily. www.sciencedaily.com/releases/2011/11/111122162822.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins